Interview — Weight Intelligence, GLP-1 and Phase 3

In conversation with Saami (Sami) Salami about building a safe weight and lifestyle engine inside Elisence

Interviewee: Saami (Sami) Salami · Founder of Elisence
Topic: Phase 3, GLP-1, and why Elisence treats weight as a long-term health journey.

1. Why did you decide to build a weight-focused phase inside Elisence?

Q: There are thousands of diet apps. Why did Elisence need Phase 3?

A: Because most of those apps focus on fast numbers, not real lives. Phase 3 was created to look at weight as part of a wider health story: sleep, mood, GLP-1 treatment, family stress, and long-term risks like diabetes and heart disease. I wanted a system that respects biology and psychology instead of selling quick fixes.

2. Your own GLP-1 experience

Q: You have personal experience with GLP-1 medications. How did that shape Phase 3?

A: It made everything very real. I saw how powerful these drugs can be for appetite and weight, but also how important it is to have structure, monitoring, and honest expectations. Phase 3 doesn’t glorify GLP-1 and it doesn’t demonise it. Instead, it helps people and clinicians see: What is happening? What is safe? What is changing?

Q: So Phase 3 tells people what dose to take or how to use GLP-1?

A: No. Elisence is very clear: we are not a prescribing system. Phase 3 is about tracking, understanding, and coaching around weight and lifestyle. Any decision about medication belongs to doctors and official guidelines, not to our algorithms.

3. What does “Weight Intelligence” mean in practice?

Q: You use the phrase “Weight Intelligence” instead of “weight loss app”. Why?

A: Because we are not selling a number on the scale. Weight Intelligence means we combine:
data — weight, trends, simple behaviours
context — sleep, movement, medication, stress
safe education — what the trends might mean, without diagnosing to help a person see their own pattern clearly. Sometimes the right move is more movement, sometimes better sleep, sometimes talking to a doctor.

Q: How does Phase 3 avoid becoming another “before/after” marketing tool?

A: We deliberately avoid aggressive promises. No “lose 10 kg in 10 days”. No “miracle reset”. Instead, we track steady progress, highlight non-scale victories like energy, mood, and clothes fitting, and we keep language grounded and respectful. This is especially important for people who already feel judged by health systems.

4. Safety, data, and long-term health

Q: Weight data can be sensitive. How is it handled inside Elisence?

A: Weight data is treated with the same seriousness as any other health signal. It goes through Zero-Trust controls, is protected by WORM-style audit, and it only appears where the person explicitly allows it. If a family shares data with a clinic or programme, there is a clear, auditable record of that choice.

Q: How does Phase 3 connect to diabetes and other conditions?

A: Phase 3 is designed to work closely with the Diabetes Phase (Phase 9) and the Nutrition Phase (Phase 16). For example, weight trends can inform a diabetes risk view, and nutrition patterns from GNIE can explain why a plateau is happening. All of this is done in a non-diagnostic way, but it creates a rich picture for people and, where appropriate, for clinicians.

5. What message do you have for someone starting a weight journey with Elisence?

Q: If someone opens Elisence today and starts logging their weight, what would you say to them?

A: I would say: be kind to yourself and be curious. Elisence is not here to shout at you. It is here to help you see what is really happening, step by step. Use the trends, use the gentle coaching, and if at any point you are worried about your health, talk to a professional. Your value is not your weight; the numbers are just one signal in a bigger story.

6. Where can people learn more about Phase 3?

Q: Where can someone go deeper into the technical side of Phase 3?

A: They can start with:
• the main “What Is Elisence?” article
• the weight and lifestyle sections of our Press & Media Kit
• and, for professionals, the longer Elisence phase reports covering Phase 3, Phase 9 (Diabetes), and Phase 16 (Nutrition).